Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600-mutant melanoma. (Record no. 30483654)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02385 a2200637 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250518080106.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 202008s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1879-0852 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/j.ejca.2019.11.016 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Ascierto, Paolo A |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20200803 |
245 00 - TITLE STATEMENT | |
Title | Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600-mutant melanoma. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | European journal of cancer (Oxford, England : 1990) |
Date of publication, distribution, etc. | 02 2020 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 33-44 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Benzimidazoles |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carbamates |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Diarrhea |
General subdivision | chemically induced |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease-Free Survival |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Melanoma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mutation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Nausea |
General subdivision | chemically induced |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Outcome Assessment, Health Care |
General subdivision | methods |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prognosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Proto-Oncogene Proteins B-raf |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Skin Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sulfonamides |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vemurafenib |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vomiting |
General subdivision | chemically induced |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Dummer, Reinhard |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gogas, Helen J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Flaherty, Keith T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Arance, Ana |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mandala, Mario |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Liszkay, Gabriella |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Garbe, Claus |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Schadendorf, Dirk |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Krajsova, Ivana |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gutzmer, Ralf |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | de Groot, Jan Willem B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Loquai, Carmen |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gollerkeri, Ashwin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pickard, Michael D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Robert, Caroline |
773 0# - HOST ITEM ENTRY | |
Title | European journal of cancer (Oxford, England : 1990) |
Related parts | vol. 126 |
-- | p. 33-44 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.ejca.2019.11.016">https://doi.org/10.1016/j.ejca.2019.11.016</a> |
Public note | Available from publisher's website |
No items available.